CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy

Allergan

Status: Completed

Conditions: Cervical Dystonia

Treatments: Other: No Intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT00836017

MedAff BTX-0718

Details and patient eligibility

About

This study is an observational trial which will measure the efficacy of onabotulinumtoxinA in treating Cervical Dystonia.

Enrollment: 1,046 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with Cervical Dystonia
• Candidate for botulinum toxin type A therapy
• New to physician's practice, and/or new to botulinum toxin type A therapy, or has not been injected with botulinum toxin type A for at least 16 weeks as a participant in another clinical trial investigating botulinum toxin type A for cervical dystonia
• Able to follow study instructions and complete study activities

Exclusion criteria

• Patients undergoing elective surgery during the trial period
• Females who are pregnant, nursing, or planning a pregnancy
• History of poor cooperation or compliance with medical treatment or unreliability
• Any condition or situation in which, in the investigator's opinion, places the patient at significant risk, could confound the study data, or may interfere with the patient's participation in the study, including but not limited to unstable medical conditions

Trial design

1,046 participants in 1 patient group

BOTOX®

Description:

Patients received BOTOX® (onabotulinumtoxinA) treatment as standard of care in clinical practice as prescribed by the physician. No intervention was administered as part of the study.

Treatment:

Other: No Intervention